INT-231

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameINT-231
Drug Alias NameNSC-344553INT-231
ClassificationSmall molecules
Mechanisms of ActionInsulin-like growth factor I receptor antagonistsAnticancer protein kinase inhibitorsFocal adhesion kinase 1 inhibitors
TargetsFocal adhesion kinase 1Insulin-like growth factor I receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Florida
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A